Drugdiscovery >> Pharmaceutical Companies >> News
1345
Views
Novartis experiences a solid growth - drugdiscovery.com
Novartis experiences a solid growth - drugdiscovery.com


Perhaps as the result of definitive agreements with GSK and Eli Lilly, Novartis announced that it has produced a solid growth in the subsequent quarter's end.
Read More >>


Tags: Novartis, sotck growth, pharmaceutical growth, novartis stocks - April 29, 2014
Related Articles
1098
Views
Dramatic job-cuts at Novartis Dramatic job-cuts at Novartis
Novartis announced 500 Swiss job cuts. The company started to outsource a large part of its services to India. Read More >>

Tags: novartis, india,jobcut, outsourcing

4115
Views
Novartis has named the new leaders of Alcon and Sandoz Novartis has named the new leaders of Alcon and Sandoz
These new leaders will set the direction for the next phase of growth for our eye care and generics businesses, two of our core growth engines. Read More >>

Tags: biosimilars, pharmaceutical business, pharma leaders, novartis, alcon, sandoz, drug, drug ceo, Chutes and Ladders, Novartis, Sandoz,

2254
Views
Novartis contributes with GSK and changes protfolio Novartis contributes with GSK and changes protfolio
Novartis announced that it is going to transform its portfolio and strenghtens its researches by acquiring products of GSK's oncology wing. Read More >>

Tags: GSK, Novartis, pharmaceutical companies, pharmaceutical news, drug discovery, oncology srugs

2264
Views
Novartis has announced the results of phase 4 INSTEAD study Novartis has announced the results of phase 4 INSTEAD study
Novartis has announced the result of a Phase 4 INSTEAD research made to imporve its new COPD drug. Once-daily indacaterol has shown very promising data. Read More >>

Tags: durg development, INSTEAD Swift study, GSK, Novartis, pharmaceutical news, pharmaceutical companies

2022
Views
A partership between Novartis and Ensemble Therapeutics A partership between Novartis and Ensemble Therapeutics
The two companies have signed the agreement to join their forces in development of experimental therapeutic candidates for the treatment of autoimmune diseases. Read More >>

Tags: Novartis, Ensemble Therapeutics, pact, partnership, inflammation, IL-17, autoimmune diseases

3920
Views
GlaxoSmithKline and Novartis sigent a three-part agreemnet GlaxoSmithKline and Novartis sigent a three-part agreemnet
GSK will accquire vaccines of Novartis. This is only one point of the three-part agreement which was signed by the two pharmaceutical giants. Both companies hope development. Read More >>

Tags: novartis, GKS, vaccination business, pharmaceutical business, pharmaceutical news, pharmaceutical business news.

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013